Genetics of ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial (2015)
- Authors:
- Autor USP: HEGG, ROBERTO - FM
- Unidade: FM
- Subjects: NEOPLASIAS MAMÁRIAS (TERAPIA;COMPLICAÇÕES); QUIMIOTERAPIA (EFEITOS ADVERSOS); HIPERTENSÃO (ETIOLOGIA)
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2015
- Source:
- Título: Journal of Clinical Oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 33, n. 15S , abstr. 547, 2015
- Conference titles: ASCO Annual Meeting
-
ABNT
MACKEY, John Robert et al. Genetics of ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/547?sid=fe5b0a84-c8e4-4c63-8084-facacd36f611. Acesso em: 11 mar. 2026. , 2015 -
APA
Mackey, J. R., Lipatov, O. N., Martin, M., Webster, M., Hegg, R., Verma, S., et al. (2015). Genetics of ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/547?sid=fe5b0a84-c8e4-4c63-8084-facacd36f611 -
NLM
Mackey JR, Lipatov ON, Martin M, Webster M, Hegg R, Verma S, Vazquez MR, Fresco R, Thireau F, Houe V, Press MF, Narasimhan A, Damaraju S. Genetics of ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2026 mar. 11 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/547?sid=fe5b0a84-c8e4-4c63-8084-facacd36f611 -
Vancouver
Mackey JR, Lipatov ON, Martin M, Webster M, Hegg R, Verma S, Vazquez MR, Fresco R, Thireau F, Houe V, Press MF, Narasimhan A, Damaraju S. Genetics of ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2026 mar. 11 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/547?sid=fe5b0a84-c8e4-4c63-8084-facacd36f611 - Eficacia, tolerabilidade e aceitabilidade do estradiol transdermico no tratamento dos sintomas da menopausa
- Sindrome do climaterio: conceito, importancia e epidemiologia
- Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study
- Câncer da mama: quadro clínico, diagnóstico e estadiamento
- Mastite puerperal
- Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA)
- Galactorreia: sindrome hiperprolactinemica
- Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
- Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer a clinical trial
- Bolero-4: A Phase 2, Open-Label, multicenter, single-arm trial investigating the efficacy and safety of first-line everolimus (EVE) in combination with letrozole (LET) in postmenopausal patients (PTS) with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2–) metastatic or locally advanced unresectable breast cancer (BC)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
